Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nobody here? This just keeps popping
A whale knows when a bio is on to something, cldx may finally hit it big! $$$
More good news an the stock gets hammered. Typical bio shorting. Could be a 100+ pps one day!
Whats the word on this freefall going on? Just shorts trying to leverage more out of it before it goes to 50+, word on the vine is they may have a huge winner coming
Something is going to be announced real soon, an its looking positive imo! $$$$
Don't forget the additional $26,500,000 million they can add.
Another $175,000,000 raised in dilution... Share price depletes
W.e. let one switch how they want, if something failed. I'd flip side as well lmao
Get lost, you got no clue who we are, lmao. If u did u would want in with us, trust me. We run stocks an avoid people like u
Crumb showed up on IDRA years ago. He was pounding the table for months telling everybody to buy it. He touted their amazing pipeline. Then they failed a Phase 3. The very next day he was short and said he had warned everyone to steer clear of the POS. He isn't a legitimate investor. If he was he wouldn't be killing time posting almost 10,000 times on IHUB. Legitimate investors invest they don't incessantly post rubbish.
Can trade in any direction and get burnt in any direction. Everyone trades differently.
Def make some either way you trade but the financials and beyond that. It's only going to get worse. It's only Phase 1b... Many phases to go 2 & 3 (a +b maybe)doubles time and phases again. That's only the phases with out going into specifics.
I have a great track record. I do the opposite of what you profess to be doing and it's been 100% successful LMAO!
Lmao, someday you might learn how to trade, GL
Great post! Truly 100% fact! Thats why we shorted it awhile back, made wealth! Currently, Possibility's are there for a reversal, whether short or long term, time will tell. We took a position before, prior to insiders buying an a hefty position when they bought. Looking like wealth again. Trading bio's is risky either way, long, short, options, etc., but if you trade them on the current state of the company's performance, an on future performance, it should lead you to which way to go. We do, an we make wealth... $$$$$
The Crumb said it. Post #1826. He bounces from short to long and back again. He's posting to himself most of the time.
That was back then, if course we shorted it then, it was a turd, now its progressed with possibilities, bio's with no proven drugs are 95% failures until they nail one, celldex may b on that track! $$$$
Who said that? Looks it by financials, Phase 1 long way to go... Revenue per share $0.15 per share...Negative -74.9% qtr yoy revenue growth. Gross Profit over negative -$35,000,000...
Huge negatives-Operating Margin -987.81%, all Profitability is mid double digit negatives
Cash Flow over negative -$70,000,000
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -987.81%
Management Effectiveness
Return on Assets (ttm) -20.02%
Return on Equity (ttm) -45.84%
Income Statement
Revenue (ttm) 5.38M
Revenue Per Share (ttm) 0.15
Quarterly Revenue Growth (yoy) -74.90%
Gross Profit (ttm) -35.12M
EBITDA -49.56M
Net Income Avi to Common (ttm) -63.69M
Diluted EPS (ttm) -1.81
Quarterly Earnings Growth (yoy) N/A
Cash Flow Statement
Operating Cash Flow (ttm) -46.38M
Levered Free Cash Flow (ttm) -23.89M
May I quote your post from 7/14/20 "Looking good shorts, keep pounding it down, nothing more than a scam pos company." First thought that comes to mind is which side are you on? Bi-polar meds are readily available friend see your physician!
Bang! This could be the next fda fast track application! $$$$
This stock has quadrupled an nobody is talking about it yet, the insiders have given everybody a hint, an if the BB boys arrive, we have a gem in the making! $$$$
Insiders are buying this up, they know good things may be finally arriving for this company. Holding strong an adding here $$$$ patience
Back over 20, this is trading like it used to way back, up an down
I prefer salami. Thanks
i covered my 7.80 a long time ago.
reshorted 10.00 covered 11.00 for a loss. went back to the well too many times.
U guys are lucky then. My average is 236 dollars now. I got fucked big with this bs company. Like I’m ever going to anything back. Yrs ago it was promising now I have no idea. I consider my money gone now. So I will not look for yrs to come n just pray they will make something happen again. GL to all ????
Somebody with the ability to manipulate wanted in cheaper. Pricks
Breakout chart. Oct 28 price breaks through previous highs in July.
You must be on vacation spending all your short play money.
Breakout chart CLDX
18.46 broke but retraced. Looking good.
Price went up and touched the Weekly 200MA, HOD at 18.46. If it can break that, shorts are really toast.
Oh damn! Another spike! If that’s how pounding works , keep pounding.
How are those puts doing today? Wrong way Feldon.
Look at the chart , that’s exactly what it is.
Looking good shorts, keep pounding it down, nothing more than a scam pos company
This is just crazy, something is wrong, this once was a very promising company with a pipeline full of possibilities, but whats left here keeping it afloat like this
Now we killn it fellow shorts, lets pound it to 1.00!
Therefore, shorting this turd to the max! $$$
I can see this at 2.50 again very soon! Lmao
Yup yup..rightfully so...hence Claytrader arriving.
It’s about to drop like hot potatoes, at over $13 now this is ridiculous!
What a SCAM ...
Ikarian and RTW bought total of 17% shares on june 10th and 11th. Their purchase price is not listed. But if you look at the historic price the low prices on that day are 3.28 and 4.29. So they likely got the shares for less than 5$. They didnt buy the shares in the secondary offering at 9$. So, its another scam by the management to boost the prices. Now the dump will begin starting monday!!
I expect a hit piece very soon...couple that with everybody sitting on a huge profit and it might finally head south. There's no justification for this market cap. Interestingly when they initially released the Phase One data the stock hardly moved. That's why I wrote the covered calls.
Followers
|
90
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1900
|
Created
|
05/29/02
|
Type
|
Free
|
Moderators |
Celldex Therapeutics, Inc. (CLDX)
http://www.celldextherapeutics.com
Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax: 908-454-1911
CIK
0000744218
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Management:
http://www.celldextherapeutics.com/about/management.php
Product Pipeline:
http://www.celldextherapeutics.com/pipeline/pipeline-overview.php
News and Press Releases:
http://ir.celldextherapeutics.com/releases.cfm
http://finance.yahoo.com/q/h?s=CLDX+Headlines
http://ir.celldex.com/releasedetail.cfm?ReleaseID=996743
Events and Presentations:
http://ir.celldextherapeutics.com/events.cfm
SEC Filings:
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000744218&owner=exclude&count=40
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications
ir@celldextherapeutics.com
----------------------------------------------
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |